Viewing Study NCT02708459


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-03-06 @ 2:31 PM
Study NCT ID: NCT02708459
Status: COMPLETED
Last Update Posted: 2016-08-30
First Post: 2016-02-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Transversus Abdominus Plane Block in Living Donor Hepatectomy
Sponsor: AlRefaey Kandeel
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2016-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TAP Donor
Brief Summary: Comparing different drugs used in Transversus abdominus plane analgesia after donor hepatectomy. Patients will be divided into three groups; control group, Bupivecaine group, and Dexmedetomedine group according to the used drug
Detailed Description: Transversus abdominus plane block for postoperative analgesia after donor hpatectomy surgery using three different drugs control group, Bupivecaine group, and Dexmedetomedine group

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: